ATARA BIOTHERAPEUTICS, INC. (ATRA) Capital expenditures 2016–2025
ATARA BIOTHERAPEUTICS, INC. (ATRA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $3.0M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $246,000 | -79.9% |
| FY2023 | $1.2M | -70.8% |
| FY2022 | $4.2M | -60.4% |
| FY2021 | $10.6M | +134.4% |
| FY2020 | $4.5M | -21.3% |
| FY2019 | $5.7M | -84.0% |
| FY2018 | $35.9M | +77.6% |
| FY2017 | $20.2M | +569.9% |
| FY2016 | $3.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice